American Cryostem Corp (fka CRYO)

[236T568]

CRYO and the China sham transactions - how scam companies do it!

1. CRYO alleges that it invested $300,000 in a Chinese company that is involved in tissue storage and processing.

then immmediately

2. CRYO alleges that it received the same $300,000 as an upfront fee from the same Chinese company.

3. Voila, all of a sudden CRYO carries a $300,000 investment as an asset in its Balance Sheet and books revenues of $300,000 in its Income Statement




https://www.sec.gov/Archives/edgar/data/1468679/000101905618000336/acryo_1q18.htm

During the first quarter of 2018, the Company invested $300,000 in Baoxin Ltd., a Chinese company that is involved in tissue storage and processing in Baoxin, China. Baoxin is not a publically traded corporation and the investment is carried at cost at December 31, 2017


Baoxin will develop, own and operate multiple laboratory/treatment/training facilities in China. CRYO has received an upfront fee of $300,000 USD and a 5 year minimum annual guarantee of $500,000 USD per year. Additionally, as part of the transaction CRYO has invested $300,000 into Baoxin to obtain 5% minority equity in Baoxin (China) and an option to acquire up to a 20% equity ownership interest in the Regenerative Medicine Center in Hong Kong (HK). The short term goals are to set up two additional GMP grade adipose tissue processing and storage facilities in Beijing and Shanghai to cover the need of the whole China region, and a proper education facility in China to promote the use of ATGRAFT as a better, more natural dermal filler over artificial fillers.